Korean Market
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceutical Largest Shareholder Kang Il-mo Slightly Increases Stake via Open Market Purchase and Partially Repays Pledged Loans

 
OWNR
KMPHARMACEUTICAL
★

Kang Il-mo Chairman Increases Stake in KM Pharmaceutical to 37.95% via Open Market Purchase, Limited Impact on Shareholder Value

 
MATR
KMPHARMACEUTICAL
★★★

KMPHARMACEUTICAL decides 16.3% dilutive rights offering to CEO to raise 1 billion won for operating funds

 
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceuticals' Largest Shareholder Kang Il-mo Slightly Increases Stake to 39.62% via Share Pledge Extensions and Open Market Purchases

 
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceutical Chairman Kang Il-mo Increases Stake by 1,200 Shares to 37.92% via Open Market Purchase

 
EXCH
KMPHARMACEUTICAL
★

KM Pharmaceutical Faces Managed Stock Designation Risk as Market Cap Remains Below 20 Billion KRW for 25 Consecutive Trading Days

 
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceutical Largest Shareholder Kang Il-mo Increases Stake by 0.26% via Open Market Purchase, Now Holds 39.60%

 
OWNR
KMPHARMACEUTICAL
★

Chairman Kang Il-mo Increases Stake in KM Pharmaceutical by 0.26% Through Open Market Purchases, Ownership Rises to 37.90%

 
EXCH
KMPHARMACEUTICAL
★

KM Pharmaceutical EGM Passes Charter and Compensation Amendments... Low Turnout and Related-Party Loan Risk Highlighted

 
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceutical Largest Shareholder Kang Il-mo Slightly Increases Stake to 39.34% via Open Market Purchase, Pledged Shares at 21.47%

 
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceutical Non-Registered Officer Kang Il-mo Acquires 1,490 Shares via Open Market Purchase — Negligible Impact on Shareholder Value

 
OWNR
KMPHARMACEUTICAL
★

KMPHARMACEUTICAL's Largest Shareholder Kang Il-mo Maintains 39.32% Stake After 5-to-1 Reverse Stock Split, Extends Pledge Loans

 
OWNR
KMPHARMACEUTICAL
★

KMPHARMACEUTICAL Non-Executive Officer Hwang Min-yeong Holds 827 Shares After Stock Split, Ownership Unchanged at 0.01%

 
OWNR
KMPHARMACEUTICAL
★

KM Pharmaceutical Non-Registered Executive Kim Jong-gi's Share Count Reduced from 2,930 to 586 Due to Stock Merge, but Stake Remains at 0.01% with No Shareholder Value Impact

 
OWNR
KMPHARMACEUTICAL
★

KMPHARMACEUTICAL CEO Baek Seung-won Reports Share Reduction via Stock Merger, Ownership Stays at 1.68 Percent with Limited Shareholder Impact